By secreting another growth factor, TGF-β1, CAFs activate the TGF-β/Smad signaling pathway in breast cancer cells, promoting their aggressive phenotype, which involves enhanced cell–ECM adhesion, migration, invasion, and EMT (109). Here, TGFB1 is linked to breast cancer.